Patents Assigned to Further Biotechnologies, LLC
  • Publication number: 20240384240
    Abstract: Provided herein are cells and methods for reprogramming iPS cells from a supercentanarian and their differentiated derivatives having differences from non-supercentenarian iPS derived cells that contribute to disease resistance and longevity. Additionally, provided herein are methods for treatment and prevention of age related diseases by administration of therapeutic sciPS derived cells or cell derived reagents. Also provided herein, are methods for identifying reagents for treatment of age related diseases using sciPS cell-based assays.
    Type: Application
    Filed: May 13, 2024
    Publication date: November 21, 2024
    Applicant: Further Biotechnologies, LLC
    Inventor: Dana Larocca